Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "herceptin"

How Mylan Is Taking On One of the World's Top Breast Cancer Drugs
Fortune

Mylan biosimilar as good as Herceptin in advanced breast cance...

CHICAGO: A biosimilar co-developed by generics giant Mylan (Nasdaq: MYL) and Indian biopharmaceutical company Biocon (NSE: BIOCON) is as effective in treating HER2 metastatic breast cancer as Herceptin (trastuzumab), according to the results of a ... Pharma Letter, 3 weeks ago
[x]  

25 images for herceptin

Fortune, 3 weeks ago
Nasdaq, 3 weeks ago
BioSpace, 3 weeks ago
RTTNews.com, 3 weeks ago
StatNews.com, 1 month ago
StatNews.com, 1 month ago
All4Women, 1 month ago
Reuters UK, 1 month ago
Yahoo! Singapore, 1 month ago
Diagnostic & Invasive Cardiology, 2 months ago
Reuters

Copycat biotech cancer drug works as well as Roche original -study

By Deena Beasley June 3 (Reuters) - A copycat version of Roche Holding AG's breast cancer drug Herceptin worked as well, and as safely, as the original biotechnology treatment in the first-ever study to compare such a "biosimilar" to a brand-name ...
 Yahoo! Finance4 weeks ago
[x]  

Roche moves court to block copies of cancer drug Avastin, A La Herceptin

MUMBAI: Swiss biotechnology giant Roche has sued the Drug Controller General of India in Delhi High Court along with Hyderabad-based Hetero Drugs over the process followed for approval of copies of complex biotech drugs or biosimilars of Avastin ...
 Economic Times1 month ago Biotech giant Roche takes NPPA to court over cap on injection price  Economic Times1 month ago Roche continues generics battle with latest lawsuit over Avastin copies  BioPharma Dive1 month ago
Reuters UK

Roche sued for allegedly overfilling Herceptin vials

Buyers are hopping mad at Roche ($RHHBY) for allegedly overfilling vials of its best-selling cancer drug, Herceptin. Now, some of them are banding together in a putative class action suit against the company over related claims. On behalf of ...
 FiercePharma1 month ago South Africa seeks price cut for Roche's Herceptin cancer drug  Yahoo! Finance UK and Ireland1 month ago UPDATE 2-South Africa seeks price cut for Roches Herceptin cancer drug  Reuters UK1 month ago South Africa seeks price cut for breast cancer drug  Global Advisors1 month ago
[x]  
DNA

High Court order not to affect product portfolio, says Biocon

Delhi High Court had prevented Biocon from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
 DNA2 months ago HC order not to impact product portfolio, says Biocon  Money Control2 months ago

Cheaper Version of Breast Cancer Drug Herceptin Performs Good during Clinical Trial

And the drug, known as biosimilar trastuzumab antibody drug MYL-1401O, works just as well as the standard but the expensive Herceptin (trastuzumab), finds a new study, funded by Mylan Pharmaceuticals. Six months later, response rates were similar ...
 Equilibrio Informativo3 weeks ago Cheaper Breast Cancer Drug Shows Promise  WebMD3 weeks ago Cheaper Breast Cancer Drug Does Well in Clinical Trial  EHE&Me3 weeks ago
[x]  

Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Revision: 29, Authorised

This is a summary of the European public assessment report (EPAR) for Herceptin. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency1 month ago
India Infoline

Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs

Justice Manmohan Singh made it clear that these companies would not call their product "bio similar" to 'Herceptin, Herclon, Biceltis', the brand names of products by firm Roche Products (India) Pvt Ltd. The Delhi High Court has allowed Biocon Ltd and Mylan ...
 India Infoline2 months ago

Forum Post: RE: Not enough margin . Breast cancer. Feeling sick

Hi Marie 20, the same happened to me and I've just had a second operation 3 weeks ago after having FEC-T and herceptin. I'm not surprised you feel unwell because the worry is significant. I was gutted when I found out the margin wasn't sufficient ...
 Macmillan Cancer Support1 month ago Forum Post: RE: Mastectomy and ovary removal  Macmillan Cancer Support2 days ago Forum Post: RE: Central line  Macmillan Cancer Support1 week ago Forum Post: RE: New to group.  Macmillan Cancer Support3 weeks ago
Business Insider

Russia Drug Maker Accuses Roche of Sabotaging Biosimilars

According to Biocad, Roche dropped prices on cancer medicines — Avastin, Herceptin, and Rituxan/MabThera — in Russia, where Biocad sells biosimilar versions of the three drugs. Source: Pharma Manufacturing
 Converter News1 week ago A Russian drug company is accusing Roche of sabotaging biosimilar competition  Business Insider1 week ago Russian drug maker says Roche tried to destroy its ability to sell biosimilars  StatNews.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - herceptin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less